Oncology Institute (TOI) Change in Account Payables (2020 - 2026)

Oncology Institute has reported Change in Account Payables for 7 years, with the latest figure at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 8.82% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.2 million (up 142.48% YoY), and the FY2025 full-year result was $19.6 million, up 113.11% from the prior year.
• Change in Account Payables for Q1 2026 stood at $4.6 million, down from $7.7 million in the prior quarter.
• The five-year high for Change in Account Payables was $7.7 million in Q4 2025, with the low at -$5.5 million in Q2 2024.
• Historically, Change in Account Payables has averaged $1.9 million across 5 years, with a median of $1.2 million in 2023.
• Annual changes were most pronounced in 2022 — Change in Account Payables slumped 725.11% — and 2024, when it surged 3508.57%.
• Oncology Institute's Change in Account Payables stood at -$1.8 million in 2022, then jumped by 161.47% to $1.1 million in 2023, then plunged by 32.57% to $739000.0 in 2024, then soared by 943.17% to $7.7 million in 2025, then sank by 40.19% to $4.6 million in 2026.
• The last three Change in Account Payables figures came in at $4.6 million (Q1 2026), $7.7 million (Q4 2025), and $439000.0 (Q3 2025), per Business Quant data.